# Keurig Dr Pepper Inc.: financial statements, quarterly

KDP · Nasdaq · CIK 1418135 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kdp.md) · [Financials](/companies/kdp/financials.md) · [Filings](/companies/kdp/filings.md) · [Insiders](/companies/kdp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kdp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,805](/filings/0001418135-24-000090.md) | [3,867 d](/filings/0001418135-26-000016.md) | [3,468](/filings/0001418135-25-000061.md) | [3,922](/filings/0001418135-25-000103.md) | [3,891](/filings/0001418135-25-000125.md) | [4,070 d](/filings/0001418135-26-000016.md) | [3,635](/filings/0001418135-26-000026.md) | [4,163](/filings/0001418135-26-000051.md) | [4,306](/filings/0001418135-25-000125.md) | [4,499 d](/filings/0001418135-26-000016.md) | [3,976](/filings/0001418135-26-000026.md) | [7,309](/filings/0001418135-26-000051.md) |
| Cost of revenue | $m | [1,694](/filings/0001418135-24-000090.md) | [1,683 d](/filings/0001418135-26-000016.md) | [1,528](/filings/0001418135-25-000061.md) | [1,750](/filings/0001418135-25-000103.md) | [1,751](/filings/0001418135-25-000125.md) | [1,793 d](/filings/0001418135-26-000016.md) | [1,650](/filings/0001418135-26-000026.md) | [1,908](/filings/0001418135-26-000051.md) | [1,966](/filings/0001418135-25-000125.md) | [2,080 d](/filings/0001418135-26-000016.md) | [1,878](/filings/0001418135-26-000026.md) | [4,243](/filings/0001418135-26-000051.md) |
| Gross profit | $m | [2,111](/filings/0001418135-24-000090.md) | [2,184 d](/filings/0001418135-26-000016.md) | [1,940](/filings/0001418135-25-000061.md) | [2,172](/filings/0001418135-25-000103.md) | [2,140](/filings/0001418135-25-000125.md) | [2,277 d](/filings/0001418135-26-000016.md) | [1,985](/filings/0001418135-26-000026.md) | [2,255](/filings/0001418135-26-000051.md) | [2,340](/filings/0001418135-25-000125.md) | [2,419 d](/filings/0001418135-26-000016.md) | [2,098](/filings/0001418135-26-000026.md) | [3,066](/filings/0001418135-26-000051.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [1,217](/filings/0001418135-24-000090.md) | [1,258 d](/filings/0001418135-26-000016.md) | [1,176](/filings/0001418135-25-000061.md) | [1,295](/filings/0001418135-25-000103.md) | [1,245](/filings/0001418135-25-000125.md) | [1,297 d](/filings/0001418135-26-000016.md) | [1,192](/filings/0001418135-26-000026.md) | [1,356](/filings/0001418135-26-000051.md) | [1,344](/filings/0001418135-25-000125.md) | [1,459 d](/filings/0001418135-26-000016.md) | [1,342](/filings/0001418135-26-000026.md) | [2,397](/filings/0001418135-26-000051.md) |
| Operating income | $m | [896](/filings/0001418135-24-000090.md) | [943 d](/filings/0001418135-26-000016.md) | [765](/filings/0001418135-25-000061.md) | [861](/filings/0001418135-25-000103.md) | [902](/filings/0001418135-25-000125.md) | [63.0 d](/filings/0001418135-26-000016.md) | [801](/filings/0001418135-26-000026.md) | [898](/filings/0001418135-26-000051.md) | [995](/filings/0001418135-25-000125.md) | [881 d](/filings/0001418135-26-000016.md) | [756](/filings/0001418135-26-000026.md) | [628](/filings/0001418135-26-000051.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [146](/filings/0001418135-24-000090.md) | [206 d](/filings/0001418135-26-000016.md) | [140](/filings/0001418135-25-000061.md) | [157](/filings/0001418135-25-000103.md) | [186](/filings/0001418135-25-000125.md) | [(10.0) d](/filings/0001418135-26-000016.md) | [143](/filings/0001418135-26-000026.md) | [171](/filings/0001418135-26-000051.md) | [190](/filings/0001418135-25-000125.md) | [104 d](/filings/0001418135-26-000016.md) | [87.0](/filings/0001418135-26-000026.md) | [95.0](/filings/0001418135-26-000051.md) |
| Net income | $m | [518](/filings/0001418135-24-000090.md) | [693 d](/filings/0001418135-26-000016.md) | [454](/filings/0001418135-25-000125.md) | [515](/filings/0001418135-25-000125.md) | [616](/filings/0001418135-25-000125.md) | [(144) d](/filings/0001418135-26-000016.md) | [517](/filings/0001418135-26-000051.md) | [547](/filings/0001418135-26-000051.md) | [662](/filings/0001418135-25-000125.md) | [353 d](/filings/0001418135-26-000016.md) | [270](/filings/0001418135-26-000051.md) | [142](/filings/0001418135-26-000051.md) |
| Diluted EPS | $ per share | [0.37](/filings/0001418135-24-000090.md) | not reported | [0.33](/filings/0001418135-25-000061.md) | [0.38](/filings/0001418135-25-000103.md) | [0.45](/filings/0001418135-25-000125.md) | not reported | [0.38](/filings/0001418135-26-000026.md) | [0.40](/filings/0001418135-26-000051.md) | [0.49](/filings/0001418135-25-000125.md) | not reported | [0.20](/filings/0001418135-26-000026.md) | [0.04](/filings/0001418135-26-000051.md) |
| Basic EPS | $ per share | [0.37](/filings/0001418135-24-000090.md) | not reported | [0.33](/filings/0001418135-25-000061.md) | [0.38](/filings/0001418135-25-000103.md) | [0.45](/filings/0001418135-25-000125.md) | not reported | [0.38](/filings/0001418135-26-000026.md) | [0.40](/filings/0001418135-26-000051.md) | [0.49](/filings/0001418135-25-000125.md) | not reported | [0.20](/filings/0001418135-26-000026.md) | [0.04](/filings/0001418135-26-000051.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001418135-23-000018.md) | [0.3](/filings/0001418135-25-000013.md) | [0.3](/filings/0001418135-24-000054.md) | [0.4](/filings/0001418135-24-000073.md) | [0.6](/filings/0001418135-24-000090.md) | [0.5](/filings/0001418135-26-000016.md) | [0.7](/filings/0001418135-25-000061.md) | [0.5](/filings/0001418135-25-000103.md) | [0.5](/filings/0001418135-25-000125.md) | [1.0](/filings/0001418135-26-000051.md) | [0.9](/filings/0001418135-26-000026.md) | [1.5](/filings/0001418135-26-000051.md) |
| Current assets | $bn | [3.4](/filings/0001418135-23-000018.md) | [3.4](/filings/0001418135-25-000013.md) | [3.6](/filings/0001418135-24-000054.md) | [3.8](/filings/0001418135-24-000073.md) | [4.1](/filings/0001418135-24-000090.md) | [4.0](/filings/0001418135-26-000016.md) | [4.3](/filings/0001418135-25-000061.md) | [4.6](/filings/0001418135-25-000103.md) | [4.7](/filings/0001418135-25-000125.md) | [5.3](/filings/0001418135-26-000051.md) | [23.1](/filings/0001418135-26-000026.md) | [9.5](/filings/0001418135-26-000051.md) |
| Total assets | $bn | [51.8](/filings/0001418135-23-000018.md) | [52.1](/filings/0001418135-25-000013.md) | [52.3](/filings/0001418135-24-000054.md) | [52.3](/filings/0001418135-24-000073.md) | [52.7](/filings/0001418135-24-000090.md) | [53.4](/filings/0001418135-26-000016.md) | [53.7](/filings/0001418135-25-000061.md) | [54.4](/filings/0001418135-25-000103.md) | [54.6](/filings/0001418135-25-000125.md) | [55.5](/filings/0001418135-26-000051.md) | [73.1](/filings/0001418135-26-000026.md) | [87.6](/filings/0001418135-26-000051.md) |
| Current liabilities | $bn | [8.8](/filings/0001418135-23-000018.md) | [8.9](/filings/0001418135-25-000013.md) | [7.0](/filings/0001418135-24-000054.md) | [7.5](/filings/0001418135-24-000073.md) | [7.7](/filings/0001418135-24-000090.md) | [8.1](/filings/0001418135-26-000016.md) | [9.2](/filings/0001418135-25-000061.md) | [7.2](/filings/0001418135-25-000103.md) | [7.5](/filings/0001418135-25-000125.md) | [8.3](/filings/0001418135-26-000051.md) | [10.0](/filings/0001418135-26-000026.md) | [19.7](/filings/0001418135-26-000051.md) |
| Total liabilities | $bn | [26.4](/filings/0001418135-23-000018.md) | [26.5](/filings/0001418135-25-000013.md) | [27.6](/filings/0001418135-24-000054.md) | [27.6](/filings/0001418135-24-000073.md) | [27.7](/filings/0001418135-24-000090.md) | [29.2](/filings/0001418135-26-000016.md) | [29.3](/filings/0001418135-25-000061.md) | [29.4](/filings/0001418135-25-000103.md) | [29.3](/filings/0001418135-25-000125.md) | [29.9](/filings/0001418135-26-000051.md) | [39.5](/filings/0001418135-26-000026.md) | [54.0](/filings/0001418135-26-000051.md) |
| Long-term debt | $bn | [9.9](/filings/0001418135-23-000018.md) | [9.9](/filings/0001418135-25-000013.md) | [12.9](/filings/0001418135-24-000054.md) | [12.4](/filings/0001418135-24-000073.md) | [12.4](/filings/0001418135-24-000090.md) | [12.9](/filings/0001418135-26-000016.md) | [11.9](/filings/0001418135-25-000061.md) | [13.9](/filings/0001418135-25-000103.md) | [13.5](/filings/0001418135-25-000125.md) | [13.0](/filings/0001418135-26-000051.md) | [20.9](/filings/0001418135-26-000026.md) | [21.6](/filings/0001418135-26-000051.md) |
| Current portion of debt | $bn | [1.6](/filings/0001418135-23-000018.md) | [1.2](/filings/0001418135-25-000013.md) | [0.0](/filings/0001418135-24-000054.md) | [0.5](/filings/0001418135-24-000073.md) | [0.5](/filings/0001418135-24-000090.md) | [1.0](/filings/0001418135-26-000016.md) | [1.0](/filings/0001418135-25-000061.md) | [0.5](/filings/0001418135-25-000103.md) | [0.9](/filings/0001418135-25-000125.md) | [0.9](/filings/0001418135-26-000051.md) | [2.0](/filings/0001418135-26-000026.md) | [3.2](/filings/0001418135-26-000051.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [25.4](/filings/0001418135-24-000090.md) | [25.7](/filings/0001418135-26-000016.md) | [24.7](/filings/0001418135-25-000125.md) | [24.7](/filings/0001418135-25-000125.md) | [25.0](/filings/0001418135-25-000125.md) | [24.2](/filings/0001418135-26-000051.md) | [24.4](/filings/0001418135-26-000051.md) | [25.0](/filings/0001418135-26-000051.md) | [25.3](/filings/0001418135-25-000125.md) | [25.5](/filings/0001418135-26-000051.md) | [25.3](/filings/0001418135-26-000051.md) | [25.0](/filings/0001418135-26-000051.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [580 d](/filings/0001418135-24-000090.md) | [297 d](/filings/0001418135-26-000016.md) | [85.0](/filings/0001418135-25-000061.md) | [657 d](/filings/0001418135-25-000103.md) | [628 d](/filings/0001418135-25-000125.md) | [849 d](/filings/0001418135-26-000016.md) | [209](/filings/0001418135-26-000026.md) | [431 d](/filings/0001418135-26-000051.md) | [639 d](/filings/0001418135-25-000125.md) | [712 d](/filings/0001418135-26-000016.md) | [281](/filings/0001418135-26-000026.md) | [895 d](/filings/0001418135-26-000051.md) |
| Capital expenditure | $m | [122 d](/filings/0001418135-24-000090.md) | [154 d](/filings/0001418135-26-000016.md) | [158](/filings/0001418135-25-000061.md) | [115 d](/filings/0001418135-25-000103.md) | [125 d](/filings/0001418135-25-000125.md) | [165 d](/filings/0001418135-26-000016.md) | [120](/filings/0001418135-26-000026.md) | [106 d](/filings/0001418135-26-000051.md) | [112 d](/filings/0001418135-25-000125.md) | [148 d](/filings/0001418135-26-000016.md) | [116](/filings/0001418135-26-000026.md) | [181 d](/filings/0001418135-26-000051.md) |
| Dividends paid | $m | [279 d](/filings/0001418135-24-000090.md) | [300 d](/filings/0001418135-26-000016.md) | [299](/filings/0001418135-25-000061.md) | [292 d](/filings/0001418135-25-000103.md) | [292 d](/filings/0001418135-25-000125.md) | [311 d](/filings/0001418135-26-000016.md) | [312](/filings/0001418135-26-000026.md) | [313 d](/filings/0001418135-26-000051.md) | [312 d](/filings/0001418135-25-000125.md) | [313 d](/filings/0001418135-26-000016.md) | [312](/filings/0001418135-26-000026.md) | [312 d](/filings/0001418135-26-000051.md) |
| Share repurchases | $m | [0.0 d](/filings/0001418135-24-000090.md) | [249 d](/filings/0001418135-26-000016.md) | [1,105](/filings/0001418135-25-000061.md) | [0.0 d](/filings/0001418135-25-000103.md) | [0.0 d](/filings/0001418135-25-000125.md) | [5.0 d](/filings/0001418135-26-000016.md) | [0.0](/filings/0001418135-25-000061.md) | [9.0 d](/filings/0001418135-26-000051.md) | [0.0 d](/filings/0001418135-25-000125.md) | [0.0 d](/filings/0001418135-26-000016.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,427](/filings/0001418135-23-000018.md) | [1,417](/filings/0001418135-24-000054.md) | [1,409](/filings/0001418135-24-000073.md) | [1,406](/filings/0001418135-24-000090.md) | [1,388](/filings/0001418135-25-000061.md) | [1,361](/filings/0001418135-25-000103.md) | [1,362](/filings/0001418135-25-000125.md) | [1,362](/filings/0001418135-26-000026.md) | [1,363](/filings/0001418135-26-000051.md) | [1,363](/filings/0001418135-25-000125.md) | [1,364](/filings/0001418135-26-000026.md) | [1,365](/filings/0001418135-26-000051.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,360,826,038 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001418135-26-000051.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.